Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

60.18
Delayed Data
As of Nov 21
 +1.59 / +2.71%
Today’s Change
39.24
Today|||52-Week Range
72.73
+44.21%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schenkein David Paul
Chief Executive Officer
Sale10/04/201780,000$70.14$5.6M-14.33%
Arch Venture Partners Llc
Director
Sale2/27/201783,750$49.13$4.1M+19.50%
Arch Venture Partners Llc
Director
Sale2/27/201757,488$50.28$2.9M+19.50%
Arch Venture Partners Llc
Director
Sale2/27/201753,985$48.36$2.6M+19.50%
Schenkein David Paul
Chief Executive Officer
Sale9/18/201735,000$67.12$2.3M-9.99%
Arch Venture Partners Llc
Director
Sale2/22/201746,938$49.90$2.3M+22.84%
Arch Venture Partners Llc
Director
Sale2/23/201742,596$47.73$2.0M+26.96%
Arch Venture Partners Llc
Director
Sale2/21/201734,650$50.56$1.8M+19.40%
Arch Venture Partners Llc
Director
Sale3/03/201731,425$50.69$1.6M+18.09%
Schenkein David Paul
Chief Executive Officer
Sale8/02/201724,000$60.55$1.5M-2.37%
Page of 13